Our earnings continued to develop strongly in the third quarter, even though the overall development of net sales was disappointing for us. Comparable EBITDA reached nearly 20%, which is almost a quarter higher than last year. Growing our earnings at a rate faster than our net sales is in line with our strategy and plans: by improving our performance and efficiency, we are laying the foundation for faster growth. Once the foundation is in place, we will shift our focus more strongly towards accelerating growth. Our return on invested capital has also continued to improve, reaching almost 13%.
We are developing our business with a long-term perspective and investing in future growth and profitability. The investments in sales, marketing and opening up new markets that were initiated last year are still continuing at a significant level.
Over the course of this year, we have made and launched several investments that support and advance our strategy. During the past quarter, we started building new laboratory facilities next to the Nokia mill and upgrading the pasta packaging equipment at the Raisio mill. Investment projects already underway include a pilot plant for research and product development and test equipment for product development. These investments will strengthen our research and development activities, improve our quality and lay the groundwork for faster growth in the future.
We are also building the Raisio of the future by investing in knowledge-based management and digital transformation. The basis for this is the project we launched at the beginning of October to renew our ERP system, which will enable us to create a stronger and more sustainable Raisio and support the implementation of our strategy. A modern cloud-based system supports the utilisation of AI features on the one hand and simplifies the integration of potential acquisitions on the other hand. The project will be implemented in two phases over the next year and a half.
In the Breakfast, Snacking & Food Solutions segment, the Elovena® brand continued its strong growth trajectory at 6% in the third quarter, but the development of the segment’s net sales was negatively impacted by domestic industrial sales and grain trading, which was higher than usual during the corresponding period last year. Lower market prices for grain have supported the profitability of the consumer business, but this has also been reflected in a decline in the net sales of the B2B business. We have launched measures to strengthen the competitiveness of our industrial sales, and we expect these measures to start bearing fruit as early as the end of this year. Extensive cost improvements, successful efficiency measures and the continued

growth of plant-based drinks in particular have contributed positively to the development of the segment’s earnings. In just four years, our oat dairy factory has grown to account for around a quarter of the total sales value of the Elovena® brand. During the summer and autumn, we have managed to improve the profitability of the Elovena® brand’s international product range, and over the next six months, our focus will be on expanding the product range and distribution.
Consumer sales in the Heart Health segment remained stable, with the largest growth in the quarter coming from higher-than-usual deliveries to industrial customers. However, since the beginning of the year, growth has been steady in both Benecol®-branded consumer products and industrial sales. Sterols play an important role in our business, but despite price fluctuations in the sterol raw material market due to increased demand from the pharmaceutical industry, our cost development has remained fairly stable overall. In line with our strategy, we have started preparations for the geographical expansion of the Benecol® business and aim to open a new Benecol® market during the first half of next year.
Pasi Flinkman
CEO, Raisio plc
November 2025
Interim Report January-September 2025